H2 receptor antagonist (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "H2 receptor antagonist" in English language version.

refsWebsite

Global rank English rank

21nih.gov

4^th place

15doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

3web.archive.org

1^st place

1clinicaltrials.gov

5,225^th place

4,062^nd place

1nobelprize.org

301^st place

478^th place

1drugs.com

399^th place

333^rd place

1harvard.edu

18^th place

17^th place

clinicaltrials.gov

Francis KL Chan (21 April 2017). "ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA". ClinicalTrials.gov. Archived from the original on 1 December 2018. Retrieved 1 November 2017.

doi.org

Panula P, Chazot PL, Cowart M, et al. (2015). "International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors". Pharmacological Reviews. 67 (3): 601–55. doi:10.1124/pr.114.010249. PMC 4485016. PMID 26084539.
Guengerich FP (2011). "Mechanisms of drug toxicity and relevance to pharmaceutical development". Drug Metabolism and Pharmacokinetics. 26 (1): 3–14. doi:10.2133/dmpk.dmpk-10-rv-062. PMC 4707670. PMID 20978361.
Gasbarrini G, Gentiloni N, Febbraro S, Gasbarrini A, Di Campli C, Cesana M, Miglio F, Miglioli M, Ghinelli F, d'Ambrosi A, Amoroso P, Pacini F, Salvadori G (1997). "Acute liver injury related to the use of niperotidine". Journal of Hepatology. 27 (3): 583–586. doi:10.1016/s0168-8278(97)80365-0. PMID 9314138.
Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS (2011). "Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis". CMAJ. 183 (3): 310–9. doi:10.1503/cmaj.092129. PMC 3042441. PMID 21173070. (adjusted odds ratio [OR] 1.22)
Meng R, Chen LR, Zhang ML, Cai WK, Yin SJ, Fan YX, Zhou T, Huang YH, He GH (2023). "Effectiveness and Safety of Histamine H2 Receptor Antagonists: An Umbrella Review of Meta-Analyses". The Journal of Clinical Pharmacology. 63 (1): 7–20. doi:10.1002/jcph.2147. PMID 36039014. S2CID 251931004.
Aizawa N, Fujita T (2023). "Physiological Role of Histamine H2 Receptor on Bladder Sensory Function in Rats". Continence. 7: 100808. doi:10.1016/j.cont.2023.100808.
Stromberga Z, Chess-Williams R, Moro C (2019). "Histamine modulation of urinary bladder urothelium, lamina propria and detrusor contractile activity via H1 and H2 receptors". Scientific Reports. 9 (1): 3899. Bibcode:2019NatSR...9.3899S. doi:10.1038/s41598-019-40384-1. PMC 6405771. PMID 30846750.
Rudick CN, Schaeffer AJ, Klumpp DJ (2009). "Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis". BMC Urology. 9: 16. doi:10.1186/1471-2490-9-16. PMC 2781023. PMID 19909543.
Zhou H, Zhou Y, Ping Y, Tian S, Li G, Cui Y, Zheng B (2019). "The combination of loratadine with famotidine to relieve the symptoms of urinary frequency in female patients with bladder function disorders：First report of three cases". Journal of Clinical Pharmacy and Therapeutics. 44 (5): 796–799. doi:10.1111/jcpt.12845. PMID 31049996. S2CID 143433911.
Thilagarajah R, Witherow RO, Walker MM (2001). "Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial". BJU International. 87 (3): 207–212. doi:10.1046/j.1464-410x.2001.02031.x. PMID 11167643. S2CID 41415547.
Thilagarajah R, Witherow RO, Walker MM (2001). "Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial". BJU International. 87 (3): 207–212. doi:10.1046/j.1464-410x.2001.02031.x. PMID 11167643. S2CID 41415547.
Dasgupta P, Sharma SD, Womack C, Blackford HN, Dennis P (2001). "Cimetidine in painful bladder syndrome: A histopathological study". BJU International. 88 (3): 183–186. doi:10.1046/j.1464-410x.2001.02258.x. PMID 11488726. S2CID 19989194.
Shan H, Zhang EW, Zhang P, Zhang XD, Zhang N, Du P, Yang Y (2019). "Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/Interstitial cystitis - significance in the responsiveness to antihistamine treatment and disease symptoms". BMC Urology. 19 (1): 115. doi:10.1186/s12894-019-0548-3. PMC 6852726. PMID 31718622.
Humphries TJ, Merritt GJ (August 1999). "Review article: drug interactions with agents used to treat acid-related diseases". Alimentary Pharmacology & Therapeutics. 13 (Suppl 3): 18–26. doi:10.1046/j.1365-2036.1999.00021.x. PMID 10491725. S2CID 2089156.
Kirch W, Hoensch H, Janisch HD (1984). "Interactions and non-interactions with ranitidine". Clinical Pharmacokinetics. 9 (6): 493–510. doi:10.2165/00003088-198409060-00002. PMID 6096071. S2CID 10715649.

drugs.com

Drugs.com "Cimetidine Side Effects" Archived 2017-11-07 at the Wayback Machine

harvard.edu

ui.adsabs.harvard.edu

Stromberga Z, Chess-Williams R, Moro C (2019). "Histamine modulation of urinary bladder urothelium, lamina propria and detrusor contractile activity via H1 and H2 receptors". Scientific Reports. 9 (1): 3899. Bibcode:2019NatSR...9.3899S. doi:10.1038/s41598-019-40384-1. PMC 6405771. PMID 30846750.

nih.gov

pubmed.ncbi.nlm.nih.gov

Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J (1995). "Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis". Eur J Gastroenterol Hepatol. 7 (5): 467–75. PMID 7614110.. A correction was published in European Journal of Gastroenterology & Hepatology 1996;8:192.
Panula P, Chazot PL, Cowart M, et al. (2015). "International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors". Pharmacological Reviews. 67 (3): 601–55. doi:10.1124/pr.114.010249. PMC 4485016. PMID 26084539.
Guengerich FP (2011). "Mechanisms of drug toxicity and relevance to pharmaceutical development". Drug Metabolism and Pharmacokinetics. 26 (1): 3–14. doi:10.2133/dmpk.dmpk-10-rv-062. PMC 4707670. PMID 20978361.
Gasbarrini G, Gentiloni N, Febbraro S, Gasbarrini A, Di Campli C, Cesana M, Miglio F, Miglioli M, Ghinelli F, d'Ambrosi A, Amoroso P, Pacini F, Salvadori G (1997). "Acute liver injury related to the use of niperotidine". Journal of Hepatology. 27 (3): 583–586. doi:10.1016/s0168-8278(97)80365-0. PMID 9314138.
Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS (2011). "Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis". CMAJ. 183 (3): 310–9. doi:10.1503/cmaj.092129. PMC 3042441. PMID 21173070. (adjusted odds ratio [OR] 1.22)
Meng R, Chen LR, Zhang ML, Cai WK, Yin SJ, Fan YX, Zhou T, Huang YH, He GH (2023). "Effectiveness and Safety of Histamine H2 Receptor Antagonists: An Umbrella Review of Meta-Analyses". The Journal of Clinical Pharmacology. 63 (1): 7–20. doi:10.1002/jcph.2147. PMID 36039014. S2CID 251931004.
Stromberga Z, Chess-Williams R, Moro C (2019). "Histamine modulation of urinary bladder urothelium, lamina propria and detrusor contractile activity via H1 and H2 receptors". Scientific Reports. 9 (1): 3899. Bibcode:2019NatSR...9.3899S. doi:10.1038/s41598-019-40384-1. PMC 6405771. PMID 30846750.
Rudick CN, Schaeffer AJ, Klumpp DJ (2009). "Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis". BMC Urology. 9: 16. doi:10.1186/1471-2490-9-16. PMC 2781023. PMID 19909543.
Zhou H, Zhou Y, Ping Y, Tian S, Li G, Cui Y, Zheng B (2019). "The combination of loratadine with famotidine to relieve the symptoms of urinary frequency in female patients with bladder function disorders：First report of three cases". Journal of Clinical Pharmacy and Therapeutics. 44 (5): 796–799. doi:10.1111/jcpt.12845. PMID 31049996. S2CID 143433911.
Thilagarajah R, Witherow RO, Walker MM (2001). "Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial". BJU International. 87 (3): 207–212. doi:10.1046/j.1464-410x.2001.02031.x. PMID 11167643. S2CID 41415547.
Thilagarajah R, Witherow RO, Walker MM (2001). "Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial". BJU International. 87 (3): 207–212. doi:10.1046/j.1464-410x.2001.02031.x. PMID 11167643. S2CID 41415547.
Dasgupta P, Sharma SD, Womack C, Blackford HN, Dennis P (2001). "Cimetidine in painful bladder syndrome: A histopathological study". BJU International. 88 (3): 183–186. doi:10.1046/j.1464-410x.2001.02258.x. PMID 11488726. S2CID 19989194.
Shan H, Zhang EW, Zhang P, Zhang XD, Zhang N, Du P, Yang Y (2019). "Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/Interstitial cystitis - significance in the responsiveness to antihistamine treatment and disease symptoms". BMC Urology. 19 (1): 115. doi:10.1186/s12894-019-0548-3. PMC 6852726. PMID 31718622.
Humphries TJ, Merritt GJ (August 1999). "Review article: drug interactions with agents used to treat acid-related diseases". Alimentary Pharmacology & Therapeutics. 13 (Suppl 3): 18–26. doi:10.1046/j.1365-2036.1999.00021.x. PMID 10491725. S2CID 2089156.
Kirch W, Hoensch H, Janisch HD (1984). "Interactions and non-interactions with ranitidine". Clinical Pharmacokinetics. 9 (6): 493–510. doi:10.2165/00003088-198409060-00002. PMID 6096071. S2CID 10715649.

ncbi.nlm.nih.gov

Panula P, Chazot PL, Cowart M, et al. (2015). "International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors". Pharmacological Reviews. 67 (3): 601–55. doi:10.1124/pr.114.010249. PMC 4485016. PMID 26084539.
Guengerich FP (2011). "Mechanisms of drug toxicity and relevance to pharmaceutical development". Drug Metabolism and Pharmacokinetics. 26 (1): 3–14. doi:10.2133/dmpk.dmpk-10-rv-062. PMC 4707670. PMID 20978361.
Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS (2011). "Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis". CMAJ. 183 (3): 310–9. doi:10.1503/cmaj.092129. PMC 3042441. PMID 21173070. (adjusted odds ratio [OR] 1.22)
Stromberga Z, Chess-Williams R, Moro C (2019). "Histamine modulation of urinary bladder urothelium, lamina propria and detrusor contractile activity via H1 and H2 receptors". Scientific Reports. 9 (1): 3899. Bibcode:2019NatSR...9.3899S. doi:10.1038/s41598-019-40384-1. PMC 6405771. PMID 30846750.
Rudick CN, Schaeffer AJ, Klumpp DJ (2009). "Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis". BMC Urology. 9: 16. doi:10.1186/1471-2490-9-16. PMC 2781023. PMID 19909543.
Shan H, Zhang EW, Zhang P, Zhang XD, Zhang N, Du P, Yang Y (2019). "Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/Interstitial cystitis - significance in the responsiveness to antihistamine treatment and disease symptoms". BMC Urology. 19 (1): 115. doi:10.1186/s12894-019-0548-3. PMC 6852726. PMID 31718622.

nobelprize.org

"Sir James W. Black - Biographical". Nobelprize.org. Archived from the original on 23 April 2015. Retrieved 7 April 2015.

semanticscholar.org

api.semanticscholar.org

Meng R, Chen LR, Zhang ML, Cai WK, Yin SJ, Fan YX, Zhou T, Huang YH, He GH (2023). "Effectiveness and Safety of Histamine H2 Receptor Antagonists: An Umbrella Review of Meta-Analyses". The Journal of Clinical Pharmacology. 63 (1): 7–20. doi:10.1002/jcph.2147. PMID 36039014. S2CID 251931004.
Zhou H, Zhou Y, Ping Y, Tian S, Li G, Cui Y, Zheng B (2019). "The combination of loratadine with famotidine to relieve the symptoms of urinary frequency in female patients with bladder function disorders：First report of three cases". Journal of Clinical Pharmacy and Therapeutics. 44 (5): 796–799. doi:10.1111/jcpt.12845. PMID 31049996. S2CID 143433911.
Thilagarajah R, Witherow RO, Walker MM (2001). "Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial". BJU International. 87 (3): 207–212. doi:10.1046/j.1464-410x.2001.02031.x. PMID 11167643. S2CID 41415547.
Thilagarajah R, Witherow RO, Walker MM (2001). "Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial". BJU International. 87 (3): 207–212. doi:10.1046/j.1464-410x.2001.02031.x. PMID 11167643. S2CID 41415547.
Dasgupta P, Sharma SD, Womack C, Blackford HN, Dennis P (2001). "Cimetidine in painful bladder syndrome: A histopathological study". BJU International. 88 (3): 183–186. doi:10.1046/j.1464-410x.2001.02258.x. PMID 11488726. S2CID 19989194.
Humphries TJ, Merritt GJ (August 1999). "Review article: drug interactions with agents used to treat acid-related diseases". Alimentary Pharmacology & Therapeutics. 13 (Suppl 3): 18–26. doi:10.1046/j.1365-2036.1999.00021.x. PMID 10491725. S2CID 2089156.
Kirch W, Hoensch H, Janisch HD (1984). "Interactions and non-interactions with ranitidine". Clinical Pharmacokinetics. 9 (6): 493–510. doi:10.2165/00003088-198409060-00002. PMID 6096071. S2CID 10715649.

web.archive.org

Francis KL Chan (21 April 2017). "ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA". ClinicalTrials.gov. Archived from the original on 1 December 2018. Retrieved 1 November 2017.
"Sir James W. Black - Biographical". Nobelprize.org. Archived from the original on 23 April 2015. Retrieved 7 April 2015.
Drugs.com "Cimetidine Side Effects" Archived 2017-11-07 at the Wayback Machine